Form 4 holding
Chief Financial Officer
C4 Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 385,098
- Estimated value
- $727,835
- Report date
- 14 Feb 2026
- Price
- $1.89
- Ownership
- Direct
Kendra Adams - Chief Financial Officer at C4 Therapeutics, Inc.
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- Chief Financial Officer
- Issuer Symbol
- CCCC on Nasdaq
- All Insider Reports
- All Insider Reports
There are no Buy or Sell transactions made by Kendra Adams since 26 May 2025
Holdings reported by Kendra Adams for C4 Therapeutics, Inc.
Form 4 holding
Chief Financial Officer
C4 Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 130,600
- Estimated value
- Report date
- 14 Feb 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transactions reported by Kendra Adams for C4 Therapeutics, Inc.
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.